This story has been updated from a previous version.

NEW YORK, April 11 - MediChem Life Sciences of Chicago said Wednesday it had signed its first protein structure deal with Celgene’s Signal Research Division, reflecting outside interest in MediChem’s drug discovery strategy, which combines its recently acquired X-ray crystallography and informatics capabilities along with its traditional medicinal chemistry approach.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.